Invesco’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $258K | Buy |
1,045,232
+44,940
| +4% | +$17.9K | ﹤0.01% | 3400 |
|
|
2025
Q4 | $420K | Buy |
1,000,292
+191,561
| +24% | +$102K | ﹤0.01% | 3266 |
|
|
2025
Q3 | $545K | Buy |
808,731
+128,279
| +19% | +$69.2K | ﹤0.01% | 3204 |
|
|
2025
Q2 | $368K | Buy |
680,452
+196,558
| +41% | +$117K | ﹤0.01% | 3291 |
|
|
2025
Q1 | $317K | Buy |
483,894
+219,253
| +83% | +$232K | ﹤0.01% | 3341 |
|
|
2024
Q4 | $270K | Sell |
264,641
-33,533
| -11% | -$61.3K | ﹤0.01% | 3446 |
|
|
2024
Q3 | $258K | Sell |
298,174
-16,347
| -5% | -$12K | ﹤0.01% | 3459 |
|
|
2024
Q2 | $113K | Buy |
314,521
+26,502
| +9% | +$14.3K | ﹤0.01% | 3736 |
|
|
2024
Q1 | $193K | Buy |
288,019
+125,745
| +77% | +$91.2K | ﹤0.01% | 3658 |
|
|
2023
Q4 | $88.2K | Sell |
162,274
-22,605
| -12% | -$10.4K | ﹤0.01% | 3701 |
|
|
2023
Q3 | $111K | Buy |
184,879
+5,597
| +3% | +$5.99K | ﹤0.01% | 3704 |
|
|
2023
Q2 | $233K | Buy |
179,282
+11,801
| +7% | +$16.1K | ﹤0.01% | 3572 |
|
|
2023
Q1 | $295K | Buy |
167,481
+26,407
| +19% | +$75.4K | ﹤0.01% | 3506 |
|
|
2022
Q4 | $443K | Buy |
141,074
+6,384
| +5% | +$24.8K | ﹤0.01% | 3334 |
|
|
2022
Q3 | $660K | Sell |
134,690
-3,779
| -3% | -$19.4K | ﹤0.01% | 3102 |
|
|
2022
Q2 | $573K | Buy |
138,469
+10,282
| +8% | +$44.5K | ﹤0.01% | 3263 |
|
|
2022
Q1 | $744K | Buy |
128,187
+41,891
| +49% | +$249K | ﹤0.01% | 3210 |
|
|
2021
Q4 | $646K | Sell |
86,296
-7,013
| -8% | -$60.9K | ﹤0.01% | 3277 |
|
|
2021
Q3 | $840K | Sell |
93,309
-708,564
| -88% | -$7M | ﹤0.01% | 3192 |
|
|
2021
Q2 | $9.6M | Buy |
801,873
+44,410
| +6% | +$503K | ﹤0.01% | 2080 |
|
|
2021
Q1 | $9.49M | Buy |
757,463
+51,023
| +7% | +$688K | ﹤0.01% | 1983 |
|
|
2020
Q4 | $11M | Buy |
706,440
+85,784
| +14% | +$1M | ﹤0.01% | 1752 |
|
|
2020
Q3 | $5.87M | Buy |
620,656
+562,474
| +967% | +$6.08M | ﹤0.01% | 1934 |
|
|
2020
Q2 | $521K | Sell |
58,182
-5,983
| -9% | -$55.5K | ﹤0.01% | 3111 |
|
|
2020
Q1 | $409K | Buy |
64,165
+39,019
| +155% | +$290K | ﹤0.01% | 3148 |
|
|
2019
Q4 | $210K | Sell |
25,146
-1,648
| -6% | -$15.2K | ﹤0.01% | 3521 |
|
|
2019
Q3 | $242K | Sell |
26,794
-1,044
| -4% | -$11.7K | ﹤0.01% | 3498 |
|
|
2019
Q2 | $300K | Sell |
27,838
-868,229
| -97% | -$9.23M | ﹤0.01% | 3503 |
|
|
2019
Q1 | $8.55M | Buy |
896,067
+271,590
| +43% | +$2.77M | ﹤0.01% | 1669 |
|
|
2018
Q4 | $7.17M | Buy |
624,477
+135,124
| +28% | +$1.68M | ﹤0.01% | 1732 |
|
|
2018
Q3 | $8.29M | Sell |
489,353
-82,159
| -14% | -$1.25M | ﹤0.01% | 1834 |
|
|
2018
Q2 | $8.12M | Sell |
571,512
-429,251
| -43% | -$7.13M | ﹤0.01% | 1801 |
|
|
2018
Q1 | $19M | Sell |
1,000,763
-375,265
| -27% | -$8.02M | 0.01% | 1194 |
|
|
2017
Q4 | $22.6M | Sell |
1,376,028
-3,177
| -0.2% | -$47.3K | 0.01% | 1154 |
|
|
2017
Q3 | $20.7M | Buy |
1,379,205
+1,324,698
| +2,430% | +$14.6M | 0.01% | 1182 |
|
|
2017
Q2 | $480K | Sell |
54,507
-456
| -0.8% | -$2.93K | ﹤0.01% | 3337 |
|
|
2017
Q1 | $286K | Buy |
54,963
+25,261
| +85% | +$101K | ﹤0.01% | 3518 |
|
|
2016
Q4 | $91K | Buy |
29,702
+829
| +3% | +$3.02K | ﹤0.01% | 3610 |
|
|
2016
Q3 | $134K | Buy |
28,873
+5,360
| +23% | +$27.3K | ﹤0.01% | 3577 |
|
|
2016
Q2 | $136K | Sell |
23,513
-87
| -0.4% | -$554 | ﹤0.01% | 3602 |
|
|
2016
Q1 | $143K | Buy |
+23,600
| New | +$142K | ﹤0.01% | 3618 |
|
|
2015
Q3 | – | Sell |
-1,356,752
| Closed | -$15M | – | 3964 |
|
|
2015
Q2 | $15M | Buy |
1,356,752
+311,858
| +30% | +$4.02M | 0.01% | 1340 |
|
|
2015
Q1 | $16.4M | Buy |
1,044,894
+914,584
| +702% | +$14.2M | 0.01% | 1300 |
|
|
2014
Q4 | $1.98M | Buy |
130,310
+21,420
| +20% | +$260K | ﹤0.01% | 2518 |
|
|
2014
Q3 | $1.18M | Sell |
108,890
-879,944
| -89% | -$11.5M | ﹤0.01% | 2873 |
|
|
2014
Q2 | $15.1M | Buy |
988,834
+741
| +0.1% | +$10.7K | 0.01% | 1356 |
|
|
2014
Q1 | $17.9M | Buy |
988,093
+820,727
| +490% | +$15.8M | 0.01% | 1240 |
|
|
2013
Q4 | $2.33M | Sell |
167,366
-528,272
| -76% | -$6.08M | ﹤0.01% | 2577 |
|
|
2013
Q3 | $7.3M | Buy |
695,638
+694,750
| +78,238% | +$6.9M | ﹤0.01% | 1659 |
|
|
2013
Q2 | $7K | Buy |
+888
| New | +$7.75K | ﹤0.01% | 4217 |
|
Other funds holding SGMO
AC
VCM
VFT
Invesco's SGMO Position: Q1 2026 in Review
Invesco increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 4.5% in Q1 2026, buying an estimated $17.9K and bringing the position to 1,045,232 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #3400.
Invesco first reported a position in SGMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $22.6M in Q4 2017. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.
- Invesco held 1,045,232 shares of SANGAMO THERAPEUTICS INC worth $258K as of Q1 2026.
- Invesco bought 44,940 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $17.9K.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3400 holding.
- Invesco first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 50 quarters since.
- Invesco's SANGAMO THERAPEUTICS INC position peaked at $22.6M in Q4 2017.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.